Literature DB >> 8774126

Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis.

T Matsuse1, A Ikegami, E Ohga, T Hosoi, T Oka, K Kida, M Fukayama, S Inoue, T Nagase, Y Ouchi, Y Fukuchi.   

Abstract

The expression of activin A, one of the transforming growth factor-beta supergene family, was studied in various pulmonary conditions associated with interstitial pulmonary fibrosis (3 cases with diffuse alveolar damage, 6 cases with idiopathic pulmonary fibrosis, and 1 case with pulmonary fibrosis associated with rheumatoid arthritis) using immunohistochemical techniques on paraffin-embedded sections. Controls consisted of 10 cases with normal pulmonary parenchyma, and 2 cases with primary pulmonary hypertension and 1 case with secondary pulmonary hypertension were also studied. The lung specimens from normal parenchyma weakly expressed immunoreactive activin A on the bronchiolar epithelium. In marked contrast, all of the specimens from cases with diffuse alveolar damage and interstitial pulmonary fibrosis demonstrated strong expression of activin A on metaplastic epithelium, hyperplastic smooth muscle cells, desquamated cells, and alveolar macrophages. Pulmonary arteries from patients with primary or secondary pulmonary hypertension showed abundant immunoreactive activin A on smooth muscle cells. These findings suggest a potential role for this growth factor, activin A, in the pathogenesis of pulmonary tissue remodeling associated with interstitial pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774126      PMCID: PMC1861725     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  A truncated activin receptor inhibits mesoderm induction and formation of axial structures in Xenopus embryos.

Authors:  A Hemmati-Brivanlou; D A Melton
Journal:  Nature       Date:  1992-10-15       Impact factor: 49.962

2.  Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin.

Authors:  M Hashimoto; A Shoda; S Inoue; R Yamada; T Kondo; T Sakurai; N Ueno; M Muramatsu
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

3.  Activin A stimulates mitogenesis in Swiss 3T3 fibroblasts without activation of mitogen-activated protein kinases.

Authors:  T Sakurai; Y Abe; Y Kasuya; N Takuwa; R Shiba; T Yamashita; T Endo; K Goto
Journal:  J Biol Chem       Date:  1994-05-13       Impact factor: 5.157

4.  Modulation of growth of vascular smooth muscle cells by activin A.

Authors:  I Kojima; H Mogami; N Kawamura; H Yasuda; H Shibata
Journal:  Exp Cell Res       Date:  1993-05       Impact factor: 3.905

5.  Modulation of activin expression by type beta transforming growth factors.

Authors:  C M van der Kruijssen; A Feijen; D Huylebroeck; A J van den Eijnden-van Raaij
Journal:  Exp Cell Res       Date:  1993-08       Impact factor: 3.905

6.  Existence of activin-A in A- and D-cells of rat pancreatic islet.

Authors:  H Yasuda; K Inoue; H Shibata; T Takeuchi; Y Eto; Y Hasegawa; N Sekine; Y Totsuka; T Mine; E Ogata
Journal:  Endocrinology       Date:  1993-08       Impact factor: 4.736

7.  Regulation of production of activin A in human marrow stromal cells and monocytes.

Authors:  L Shao; N L Frigon; D W Sehy; A L Yu; J Lofgren; R Schwall; J Yu
Journal:  Exp Hematol       Date:  1992-11       Impact factor: 3.084

8.  Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-gamma production.

Authors:  F Petraglia; P Sacerdote; A Cossarizza; S Angioni; A D Genazzani; C Franceschi; M Muscettola; G Grasso
Journal:  J Clin Endocrinol Metab       Date:  1991-02       Impact factor: 5.958

9.  Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis.

Authors:  T J Broekelmann; A H Limper; T V Colby; J A McDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

10.  Activin A/erythroid differentiation factor is induced during human monocyte activation.

Authors:  M Erämaa; M Hurme; U H Stenman; O Ritvos
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  17 in total

1.  Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25.

Authors:  Lisa G Gregory; Sara A Mathie; Simone A Walker; Sophie Pegorier; Carla P Jones; Clare M Lloyd
Journal:  Am J Respir Crit Care Med       Date:  2010-03-25       Impact factor: 21.405

2.  Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis.

Authors:  T Matsuse; E Ohga; S Teramoto; M Fukayama; R Nagai; S Horiuchi; Y Ouchi
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

Review 3.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

4.  Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo.

Authors:  J E Pawlowski; D S Taylor; M Valentine; M E Hail; P Ferrer; M C Kowala; C J Molloy
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

5.  Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A.

Authors:  R M Nüsing; J Barsig
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

6.  Role of activins and inducible nitric oxide in the pathogenesis of ectopic pregnancy in patients with or without Chlamydia trachomatis infection.

Authors:  Bassem Refaat; Majedah Al-Azemi; Ian Geary; Adrian Eley; William Ledger
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

7.  Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer.

Authors:  K S Kraunz; H H Nelson; M Liu; J K Wiencke; K T Kelsey
Journal:  Br J Cancer       Date:  2005-10-17       Impact factor: 7.640

8.  Upregulation of activin-B and follistatin in pulmonary fibrosis - a translational study using human biopsies and a specific inhibitor in mouse fibrosis models.

Authors:  Marjukka Myllärniemi; Jussi Tikkanen; Juha J Hulmi; Arja Pasternack; Eva Sutinen; Mikko Rönty; Outi Leppäranta; Hongqiang Ma; Olli Ritvos; Katri Koli
Journal:  BMC Pulm Med       Date:  2014-11-01       Impact factor: 3.317

9.  Deficient Follistatin-like 3 Secretion by Asthmatic Airway Epithelium Impairs Fibroblast Regulation and Fibroblast-to-Myofibroblast Transition.

Authors:  Richard G James; Stephen R Reeves; Kaitlyn A Barrow; Maria P White; Veronika A Glukhova; Candace Haghighi; Dana Seyoum; Jason S Debley
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 7.748

10.  Follistatin, an activin antagonist, ameliorates renal interstitial fibrosis in a rat model of unilateral ureteral obstruction.

Authors:  Akito Maeshima; Keiichiro Mishima; Shin Yamashita; Masao Nakasatomi; Masaaki Miya; Noriyuki Sakurai; Toru Sakairi; Hidekazu Ikeuchi; Keiju Hiromura; Yoshihisa Hasegawa; Itaru Kojima; Yoshihisa Nojima
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.